JP2009511516A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511516A5
JP2009511516A5 JP2008534894A JP2008534894A JP2009511516A5 JP 2009511516 A5 JP2009511516 A5 JP 2009511516A5 JP 2008534894 A JP2008534894 A JP 2008534894A JP 2008534894 A JP2008534894 A JP 2008534894A JP 2009511516 A5 JP2009511516 A5 JP 2009511516A5
Authority
JP
Japan
Prior art keywords
ylmethyl
aminopyridin
alkylene
propionic acid
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008534894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511516A (ja
JP5266053B2 (ja
Filing date
Publication date
Priority claimed from DE102005049385A external-priority patent/DE102005049385A1/de
Application filed filed Critical
Publication of JP2009511516A publication Critical patent/JP2009511516A/ja
Publication of JP2009511516A5 publication Critical patent/JP2009511516A5/ja
Application granted granted Critical
Publication of JP5266053B2 publication Critical patent/JP5266053B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008534894A 2005-10-15 2006-09-30 TAFIaのインヒビターとしてのイミダゾール誘導体 Expired - Fee Related JP5266053B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005049385.8 2005-10-15
DE102005049385A DE102005049385A1 (de) 2005-10-15 2005-10-15 Imidazolderivate als Inhibitoren von TAFIa
PCT/EP2006/009500 WO2007045339A1 (de) 2005-10-15 2006-09-30 Imidazolderivate als inhibitoren von tafi-a

Publications (3)

Publication Number Publication Date
JP2009511516A JP2009511516A (ja) 2009-03-19
JP2009511516A5 true JP2009511516A5 (https=) 2009-11-19
JP5266053B2 JP5266053B2 (ja) 2013-08-21

Family

ID=37733974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008534894A Expired - Fee Related JP5266053B2 (ja) 2005-10-15 2006-09-30 TAFIaのインヒビターとしてのイミダゾール誘導体

Country Status (12)

Country Link
US (1) US8044208B2 (https=)
EP (1) EP1937673B1 (https=)
JP (1) JP5266053B2 (https=)
CY (1) CY1117379T1 (https=)
DE (1) DE102005049385A1 (https=)
DK (1) DK1937673T3 (https=)
ES (1) ES2558874T3 (https=)
HU (1) HUE026577T2 (https=)
PL (1) PL1937673T3 (https=)
PT (1) PT1937673E (https=)
SI (1) SI1937673T1 (https=)
WO (1) WO2007045339A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103432A2 (en) * 2008-02-21 2009-08-27 Sanofi-Aventis Covalently binding imaging probes
WO2010050525A1 (ja) 2008-10-29 2010-05-06 大正製薬株式会社 TAFIa阻害活性を有する化合物
BR112012023412A2 (pt) 2010-03-18 2018-05-08 Daiichi Sankyo Company, Limited composto, drogra farmacêutica, inibidor de tafia, promotor de fibrinólise, droga preventiva ou terapêutica, composição farmacêutica, e, uso de um composto.
EP2548871B1 (en) 2010-03-18 2017-07-19 Daiichi Sankyo Company, Limited Cycloalkyl-substituted imidazole derivative
KR101799429B1 (ko) 2010-05-03 2017-11-21 에스케이바이오팜 주식회사 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
KR20160018557A (ko) 2013-06-10 2016-02-17 사노피 TAFIa의 저해제로서의 마크로사이클릭 우레아 유도체, 이의 제법 및 의약품으로서의 이의 용도
MX2022007376A (es) 2019-12-20 2022-09-02 Tenaya Therapeutics Inc Fluoroalqull-oxadiazoles y sus usos.
US20240252502A1 (en) 2021-05-04 2024-08-01 Tenaya Therapeutics, Inc. Hdac6 inhibitors for treatment of metabolic disease and hfpef

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE447557T1 (de) * 2000-08-17 2009-11-15 Pfizer Ltd Substitutuierte imidazole als tafia inhibitoren
WO2003013526A1 (en) * 2001-08-08 2003-02-20 Merck & Co. Inc. Anticoagulant compounds
BR0307033A (pt) * 2002-01-22 2004-12-07 Pfizer ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas

Similar Documents

Publication Publication Date Title
ES2665036T3 (es) Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas
CA2346396C (en) 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
ES2276803T3 (es) Inhibidores de polimerasa viral.
ES2246240T3 (es) Bencimidazoles sustituidos.
JP2009511516A5 (https=)
CN115894463A (zh) 一种rock抑制剂的制备方法、其中间体及中间体的制备方法
EP2523664A1 (en) Compounds and methods
ES2782509T3 (es) Procedimiento para la preparación de 1,2,4-oxadiazoles 3,5-disustituidos
JP2003300959A5 (https=)
AU2005210004A1 (en) Novel inhibitors of glutaminyl cyclase
BRPI1008498B1 (pt) Compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto
WO2013066831A1 (en) Compounds and methods
WO1999052525A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
JP2007519695A5 (https=)
US20110224208A1 (en) Novel inhibitors of flavivirus replication
RU2303032C2 (ru) Замещенные дикетопиперазины как антагонисты окситоцина
JP2010503625A5 (https=)
CN101987848A (zh) 新的二氢吲哚酮化合物、它们的制备方法以及包含它们的药物组合物
Tran et al. In vitro and in silico determination of glutaminyl cyclase inhibitors
JP2011521981A5 (https=)
CN102924443B (zh) 含有杂环的5-羟基吲哚类衍生物及其用途
AU2016362394A1 (en) Heterocycle compounds and uses thereof
JP2007505105A5 (https=)
TW201339153A (zh) 包含hcv ns5a之抑制劑的固體形式、其組合物及其用途
JP2010519278A5 (https=)